ErbB2 assay in breast cancer: Possibly improved clinical information using a quantitative method

Anticancer Research

Volumn 17, Issue 2B, 1997, Pages 1245-1248

  Dittadi, Ruggero ^a,e   Brazzale, Alessandra ^a   Pappagallo, Gianluigi ^b   Salbe, Cristina ^a   Nascimben, O ^c   Rosabian, A ^d   Gion, Massimo ^a  

^a Regional General Hospital   (Italy)

^b PF Calvi Hospital   (Italy)

^c Ospedale Umberto I   (Italy)

^d Boldrini Hospital   (Italy)

^e Ospedale Civile   (Italy)

Author keywords

Breast cancer; ErbB2 neu; p185; Risk

Indexed keywords

ONCOPROTEIN;

ADULT; ARTICLE; BREAST CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SURVIVAL;

BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0030889953     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Hynes NE, Stern DF: The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1198: 165-184, 1994.
2. De Potter CR, Schelfhout A-M: The neu-protein and breast cancer. Virchows Arch. 426: 107-115, 1995.
3. Loprinzi CL, Ravdin P, DE Laurentiis M, Novotny P: Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? J Clin Oncol 12: 1422-1426, 1994.
4. Dittadi R, Donisi PM, Brazzale A, Marconato R, Spina M and Gion M: Immunoenzyymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters. Anticancer Res 12: 1821-1824, 1992.
5. Dittadi R, Catozzi L, Gion M, Brazzale A, Capitanio G, Gelli MC, Menegon A, Gardini G, Malagutti R and Piffanelli A: Comparison between Western blotting, immunohistochemical and ELISA assay for 185neu quantitation in breast cancer specimens. Anticancer Res 13: 1821-1824, 1993.
6. Piffanelli A, Dittadi R, Catozzi L, Gion M, Capitanio G, Gelli MC, Brazzale A, Malagutti R, Pelizzola D, Menegon A, Giovannini G, Gardini G. Determination of ErbB2 protein in breast cancer tissues by different methods. Relationships with other biological parameters. Breast Cancer Res Treatment 37: 267-276, 1996.
7. EORTC Breast Cancer Cooperative Groop. Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J. Cancer Clin Oncol 16: 1513-1515, 1980.
8. Cuny M, Simony-Lafontaine J, Rouanet P, Grenier J, Valles H, Lavaill R, Louason G, Causse A, Lequeux N, Thierry C, JeanteurP, Theillet C: Quantification of ERBB2 protein expression in breast cancer: three levels of expression defined by their clinico-pathological correlations. Oncol Res 6: 169-176, 1994.
9. Digiovanna MP, Stern DF: Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor. Cancer Res 55: 1946-1955, 1995.